News & Events The Peptide Products Division in JYMed has flawlessly passed on-site inspection from FDA.

Vehementer gratulamur nostro Polypeptide Products Division quod feliciter transitum US FDA in-situm cum "nulla defectibus"!

FDA inspectio in-site transeundo cum "nulla defectibus" maior est eventus in historia nostra cGMP evolutionis.Non solum significat nostrum API diplomate ad mercatum US ingrediendum consecutus, sed etiam probat exsecutionem cGMP in societate nostra sensim cum signis internationalibus congruere.